CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

North American Expert Review of Rotational Atherectomy Treating Bifurcation Lesions: The Result Overcomes the Technique Orbital atherectomy for the treatment of small (2.5mm) severely calcified coronary lesions: ORBIT II sub-analysis Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II) Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial Temporal changes in radial access use, associates and outcomes in patients undergoing PCI using rotational atherectomy between 2007 and 2014: results from the British Cardiovascular Intervention Society national database Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review Intravascular ultrasound enhances the safety of rotational atherectomy
|<<... 161 162 163 164 165 166 167 ...>>|

JOURNAL： Article Link

​AsiaIntervention正式被PubMed Central收录

admin


AsiaIntervention is the official journal of the Asian Pacific Society of Interventional Cardiology (APSIC) and the Interventional Cardiology Foundation of India (ICFI). Driven by a group of recognised experts worldwide, AsiaIntervention is an international, English language, peer-reviewed journal whose aim is to create a forum of high-quality research and educational articles in the field of percutaneous and surgical cardiovascular interventions with particular emphasis on scientific contributions from the Asia-Pacific region.


亚太地区人口占世界人口的60%以上，在经济高速发展的同时，介入心脏病学发展速度也领先全球。 为进一步满足亚太地区医学界科研成果交流的愿景，着力突出亚太地区学者的科学贡献，在亚太介入心脏病学会（the Asian Pacific Society of Interventional Cardiology, APSIC）与印度介入心脏病基金会（ICFI）的共同努力下，AsiaIntervention这一接收全世界投稿、同行评议、英文版心血管病介入杂志应运而生，其创刊愿景是构建一个由具全球高学术影响力的心血管专家推动的服务于经皮和外科心血管干预领域学术交流和教育的高水平平台。AsiaIntervention编委会成员由来自亚太和欧洲地区知名编辑组成，保障了杂志的专业多元化和独立性。五位总编由来自领域内有声望的副主编和责编协助，我院陈绍良教授荣任副主编。


AsiaIntervention接收文章类型多元，涉及原创研究、临床研究、名家综述、专题报道、评论文章和心脏病学影像等多种形式。发表前由编辑委员会和选中的介入心脏病学的专家评审，同行评审过程为单盲。杂志每年出版两期，包括印刷版和电子版。



自2015年创刊后，AsiaIntervention于近期申请了Science Citation Index® (ISI)、SciVerse Scopus、MEDLINE®/PubMed®索引收录，并于2021年12月17日正式获PubMed Central收录。



点击阅读原文可直接访问AsiaIntervention官方网站在线投稿，陈绍良教授诚邀各位心血管临床和科研工作者积极投稿。







>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top